AGH heart specialists to join clinical trial
By Rick Wills
Published: Wednesday, March 14, 2012
Heart specialists at Allegheny General Hospital announced today that they will join a clinical trial investigating an implantable device designed to provide patients with coronary artery disease an early warning of an impending heart attack.
AGH is the only Pittsburgh area hospital testing the new device — the AngelMed Guardian System.
"Patient outcomes following heart attack are largely dependent upon how quickly the cardiac injury is diagnosed and therapeutic efforts are initiated to restore blood flow to the heart. Delays in that process can result in permanent damage to heart muscle," said Dr. David Lasorda, director of the hospital's division of Interventional cardiology and its principal investigator in the study.
The American Heart Association estimates that one of every five deaths in the United States is attributable to coronary heart disease. Furthermore, 50 percent of heart-attack fatalities occur within one hour of symptom onset and often before the patient even reaches the hospital.
- Steelers hope new blocking scheme kick-starts running game
- NHL commissioner Bettman talks Crosby, Olympics, outdoor games
- Senators' Alfredsson clarifies comments made after Game 4
- Penguins insider: Golden opportunity arrives with Game 5
- Steelers notebook: Gilbert hopes to stay on left side of O-line
- Starkey: Pens’ offense blazing historic path
- 3 arrested in break-in at Allegheny Ludlum plant
- Pirates notebook: Melancon relishes rare save opportunity
- Pirates beat Cubs, 4-2, to finish homestand with sweep
- Mt. Pleasant to dedicate new digital wall
- Pens will unveil even bigger TV screen for fans in Game 5
You must be signed in to add comments
To comment, click the Sign in or sign up at the very top of this page.